These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias. Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705 [TBL] [Abstract][Full Text] [Related]
24. Blockade of CaMKII depresses conduction preferentially in the right ventricular outflow tract and promotes ischemic ventricular fibrillation in the rabbit heart. Warren M; Sciuto KJ; Taylor TG; Garg V; Torres NS; Shibayama J; Spitzer KW; Zaitsev AV Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H752-H767. PubMed ID: 28130334 [TBL] [Abstract][Full Text] [Related]
25. Autonomous activation of CaMKII exacerbates diastolic calcium leak during beta-adrenergic stimulation in cardiomyocytes of metabolic syndrome rats. Romero-García T; Landa-Galvan HV; Pavón N; Mercado-Morales M; Valdivia HH; Rueda A Cell Calcium; 2020 Nov; 91():102267. PubMed ID: 32920522 [TBL] [Abstract][Full Text] [Related]
26. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft. Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757 [TBL] [Abstract][Full Text] [Related]
28. Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Osadchii OE; Norton GR; McKechnie R; Deftereos D; Woodiwiss AJ Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1898-905. PubMed ID: 17158652 [TBL] [Abstract][Full Text] [Related]
29. miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Terentyev D; Belevych AE; Terentyeva R; Martin MM; Malana GE; Kuhn DE; Abdellatif M; Feldman DS; Elton TS; Györke S Circ Res; 2009 Feb; 104(4):514-21. PubMed ID: 19131648 [TBL] [Abstract][Full Text] [Related]
30. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis. Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519 [TBL] [Abstract][Full Text] [Related]
31. Ca2+/calmodulin-dependent protein kinase II increases the susceptibility to the arrhythmogenic action potential alternans in spontaneously hypertensive rats. Mitsuyama H; Yokoshiki H; Watanabe M; Mizukami K; Shimokawa J; Tsutsui H Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H199-206. PubMed ID: 24858851 [TBL] [Abstract][Full Text] [Related]
32. Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure. Zhang X; Cheng HJ; Zhou P; Kitzman DW; Ferrario CM; Li WM; Cheng CP Int J Cardiol; 2017 Jun; 236():405-412. PubMed ID: 28096047 [TBL] [Abstract][Full Text] [Related]
33. Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemic-reperfusion-induced cardiac dysfunction. Yu Z; Wang ZH; Yang HT Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H735-42. PubMed ID: 19525372 [TBL] [Abstract][Full Text] [Related]
34. Ca2+/calmodulin kinase II increases ryanodine binding and Ca2+-induced sarcoplasmic reticulum Ca2+ release kinetics during beta-adrenergic stimulation. Ferrero P; Said M; Sánchez G; Vittone L; Valverde C; Donoso P; Mattiazzi A; Mundiña-Weilenmann C J Mol Cell Cardiol; 2007 Sep; 43(3):281-91. PubMed ID: 17643448 [TBL] [Abstract][Full Text] [Related]
35. Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility. Li T; Zhang X; Cheng HJ; Zhang Z; Ahmad S; Varagic J; Li W; Cheng CP; Ferrario CM Int J Cardiol; 2018 Aug; 264():137-144. PubMed ID: 29685688 [TBL] [Abstract][Full Text] [Related]
36. Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor. Neef S; Steffens A; Pellicena P; Mustroph J; Lebek S; Ort KR; Schulman H; Maier LS J Mol Cell Cardiol; 2018 Feb; 115():73-81. PubMed ID: 29294328 [TBL] [Abstract][Full Text] [Related]
37. Sustained CaMKII activity mediates transient oxidative stress-induced long-term facilitation of L-type Ca(2+) current in cardiomyocytes. Song YH; Choi E; Park SH; Lee SH; Cho H; Ho WK; Ryu SY Free Radic Biol Med; 2011 Nov; 51(9):1708-16. PubMed ID: 21854842 [TBL] [Abstract][Full Text] [Related]
38. Small-conductance Ca2+-activated K+ current is upregulated via the phosphorylation of CaMKII in cardiac hypertrophy from spontaneously hypertensive rats. Mizukami K; Yokoshiki H; Mitsuyama H; Watanabe M; Tenma T; Takada S; Tsutsui H Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1066-74. PubMed ID: 26297230 [TBL] [Abstract][Full Text] [Related]
39. Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. Wang Y; Tandan S; Cheng J; Yang C; Nguyen L; Sugianto J; Johnstone JL; Sun Y; Hill JA J Biol Chem; 2008 Sep; 283(37):25524-25532. PubMed ID: 18622016 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation. Curran J; Tang L; Roof SR; Velmurugan S; Millard A; Shonts S; Wang H; Santiago D; Ahmad U; Perryman M; Bers DM; Mohler PJ; Ziolo MT; Shannon TR PLoS One; 2014; 9(2):e87495. PubMed ID: 24498331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]